Category: Prescription Drugs
United States Prescription Drugs
-
U.S. Dietary Supplements Market Size, Share & Trends Analysis Report By Type (OTC, Prescribed), By Ingredient, By Form, By Application, By End-user, By Distribution Channel, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. dietary supplements market size is expected to reach USD 78.94 billion by 2030, registering a CAGR of 5.7% from 2023 to 2030, according to a new report by Grand View ... Read More
-
The U.S. Medical Weight Loss Market
... greater focus on medical weight loss programs using the new obesity drugs. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy, Ozempic and Saxenda, with more new ... Read More
-
US Electric Bus Market 2022-2028
... in the country is among the key factors to drive the growth of the electric bus market in the US. The US Federal Transit Administration (FTA) had offered several grants for the purchase of electric ... Read More
-
The U.S. Weight Loss & Diet Control Market
... Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
U.S. Diabetic Neuropathy Market, by Drug (Tricyclic Antidepressants (Amitriptyline, Nortyptyline, Imipramine, Desipramine), SSRI (Paroxetine, Citalopram), Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine), Opioids (Tramadol, Tapentadol, Oksikodon), SNRIs (Duloxetine), Other Drugs (Capsaicin, Lidocaine, Botilinum Toxin)) by Type (Peripheral Neuropathy, Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetic neuropathy is ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
United States Healthcare Fraud Detection Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 epidemic illustrates how public health crises affect emergency departments and hospital systems. The pandemic of COVID-19 had a tremendous impact on healthcare delivery. Urgent adjustments in billing codes, telehealth, and prescriptions enabled health care ... Read More
-
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 446110
... of research. Key Findings: Pharmacies and Drug Stores Industry (U.S.) to reach $333,908,294,300 million by 2029. Pharmacies and Drug Stores Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1) ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 424200
... countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $916,620,445,623 million by 2029. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
The U.S. Autism Treatment Centers Market
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
Epilepsy Medication Manufacturing in the US - Industry Market Research Report
... report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players ... Read More
-
North America Osteoporosis Treatment Market, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Rank Ligand Inhibitor and Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Pharmacies and Others), By Country (U.S. and Canada), Trend Analysis, Competitive Market Share & Forecast, 2018-2028 North America Osteoporosis Treatment Market to Cross USD 10.25 Billion by 2028 North America Osteoporosis Treatment Market is growing ... Read More
-
U.S. Opioids Market, by Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone), by Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids ... Read More
-
U.S. Behavioral Health Care Software And Services Market Size, Share & Trends Analysis Report By Component (Software, Support Services), By Delivery Model, By Function, By End Use, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.12% from 2022 to 2030. An increase in the adoption of technological solutions for the management of clinical, administrative, and ... Read More
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2022-2028
... market growth is driven by regular cognitive assessments of senior citizens and the easy availability of relevant drugs. MARKET INSIGHTS Alzheimer’s is a degenerative disorder that attacks the neurons, affecting thinking, memory loss, behavioral changes, ... Read More
-
Controlled Substance Market (Product Type: Opioids, Stimulants, Depressants, and Cannabinoids) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... controlled substance market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report ... Read More
-
U.S. Degenerative Disc Disease Treatment Market, by Treatment (Epidural Steroid Injections, Narcotics (Morphine, Methadone Hydrochloride, Codeine, Hydrocodone, Tramodol, Oxycodone, and Others), Orthobiologics (Includes Biomolecular/Gene Therapy, Cell-base
... Phase III), by Disease Indication (Early Stage, Mid Stage, and Late Stage), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Degenerative disc ... Read More
-
U.S. Injectable Compounding Pharmacy Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl / Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacain
... (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin, and Others), by Packaging Type (Vials, Ampoules, Prefilled Syringes, and Others), and by Pharmacy Type (503A Pharmacies and 503B Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
U.S. Compounding Pharmacies Market, By Medication (Oral Medication(Capsules, Tablets, Mixtures, Lollipops, Lozenges),Topical Medication(Gels, Ointments, Cream, Lotions), Mouthwashes, Suppositories), By Therapeutic Area (Pain Management, Hormone Replacemen
... Medication for Children, Medication for Geriatric) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Compounding pharmacies consist of creation/compounding of pharmaceutical products tailored to fit the needs of the patient. Compounding pharmacies is ... Read More
-
U.S. 503B Compounding Pharmacies Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/Bupivacaine, Morphine, Amiodarone, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BK
... Ketorolac, and Ketamine), and Other Molecules), and by Packaging (Vials, Prefilled Syringes, Ampoules, Syringes, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 In the U.S. 503B compounding pharmacies market, conventional compounding ... Read More
-
How To Set Up A Profitable Medical Weight Loss Program
... franchises, and independent physicians generate $1.6 billion. Many MDs would love to grab a piece of this market, but don’t have the marketing and business background to know how. This completely revised and updated Guide ... Read More
-
CVS Pharmacy, United States of America (USA) (Health and Beauty) Shoppers Profile, Market Share and Competitive Positioning
... the market, with a slightly higher share among the male shopper base (50.9%). Profile of retailer’s shopper base, key performance indicators, sales and market shares Scope CVS’ vast store network across the US makes it ... Read More
-
USA Nasal Decolonization Market Insights, Forecast to 2028
... 105.76 million by the end of 2028, growing at a CAGR of 7.49% during 2022-2028. USA Nasal Decolonization Scope and Segment Nasal Decolonization market is segmented by type, and by application. Players, stakeholders, and other ... Read More
Research Assistance
